TTC26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.438600E-01
Normal-vs-Stage2
7.240600E-01
Normal-vs-Stage3
4.173800E-01
Normal-vs-Stage4
4.448800E-01
Stage1-vs-Stage2
5.174400E-01
Stage1-vs-Stage3
4.926300E-02
Stage1-vs-Stage4
5.945400E-01
Stage2-vs-Stage3
2.543600E-01
Stage2-vs-Stage4
1.860580E-01
Stage3-vs-Stage4
2.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.600800E-01
Normal-vs-AfricanAmerican
4.537600E-01
Normal-vs-Asian
7.543000E-01
Caucasian-vs-AfricanAmerican
5.201200E-01
Caucasian-vs-Asian
1.767830E-01
AfricanAmerican-vs-Asian
1.471050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.400600E-01
Normal-vs-Female
5.840000E-01
Male-vs-Female
4.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.563400E-01
Normal-vs-Age(41-60Yrs)
4.226000E-01
Normal-vs-Age(61-80Yrs)
8.222600E-01
Normal-vs-Age(81-100Yrs)
9.139600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.922200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.830200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.675800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.356130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.657990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.337000E-01
Normal-vs-Daily Drinker
8.538200E-01
Normal-vs-Weekly Drinker
8.371400E-01
Normal-vs-Occasional Drinker
4.911400E-01
Normal-vs-Social Drinker
4.666600E-01
Non Drinker-vs-Daily Drinker
5.518200E-01
Non Drinker-vs-Weekly Drinker
6.091200E-01
Non Drinker-vs-Occasional Drinker
9.492000E-02
Non Drinker-vs-Social Drinker
1.040400E-01
Daily Drinker-vs-Weekly Drinker
9.432000E-01
Daily Drinker-vs-Occasional Drinker
1.938840E-01
Daily Drinker-vs-Social Drinker
1.915560E-01
Weekly Drinker-vs-Occasional Drinker
1.830190E-01
Weekly Drinker-vs-Social Drinker
1.939370E-01
Occasional Drinker-vs-Social Drinker
9.967200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.718600E-01
Normal-vs-Grade 2
4.016600E-01
Normal-vs-Grade 3
3.089200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.598600E-01
Grade 1-vs-Grade 3
4.125800E-01
Grade 1-vs-Grade 4
5.718600E-01
Grade 2-vs-Grade 3
5.493600E-01
Grade 2-vs-Grade 4
4.016600E-01
Grade 3-vs-Grade 4
3.089200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.292200E-01
Normal-vs-NonDiabetic
6.950400E-01
Diabetic-vs-NonDiabetic
2.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.452600E-01
Normal-vs-NoPancreatitis
6.988400E-01
Pancreatitis-vs-NoPancreatitis
2.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.166000E-01
Normal-vs-N1
6.784000E-01
N0-vs-N1
8.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.325400E-01
Normal-vs-TP53-NonMutant
5.296200E-01
TP53-Mutant-vs-TP53-NonMutant
5.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
